Latest filing published 02 Mar 2022 for Karyopharm Therapeutics Inc., €15k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -72.4%Entry US$481.20 · Close at T+365 US$132.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ran Frenkel: trading record in brief
Ran Frenkel (senior executive) discloses dealings in Karyopharm Therapeutics Inc. to SEC (Form 4). In total, 18 filings cover trades dated from 6 April 2015 to 28 February 2022.
The open-market side counts 2 purchases for €88k alongside 9 sales for €286k. On balance, insiders were net sellers of €198k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 2 share grants and 5 option exercises. In 2022 alone, the filings show no purchases and 3 sales.
The record was last updated on 2 March 2022 with an open-market sale (€15k) in Karyopharm Therapeutics Inc. The most recent open-market purchase was published on 8 April 2015, 4,232 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Ran Frenkel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,663 shares@ US$10.24Common StockSEC:0001209191-22-014629:1
- 68,250 shares0Common StockSEC:0001209191-22-014629:0
- 2,929 shares@ US$12.123464.6% of flowCommon StockSEC:0001209191-22-011643:0
- 1,991 shares@ US$9.86235.4% of flowCommon StockSEC:0001209191-22-008128:0
- 22,013 shares0Common StockSEC:0001209191-21-015484:0
- 2,887 shares@ US$14.83Common StockSEC:0001209191-21-012967:0
- 2,046 shares@ US$15.52Common StockSEC:0001209191-21-011490:0
- 9,675 sharesCommon StockSEC:0001209191-21-011490:1
- 5,650 sharesCommon StockSEC:0001209191-21-009079:0
- 1,974 shares@ US$20.00Common StockSEC:0001209191-20-028271:0
- 2,975 shares@ US$16.48Common StockSEC:0001209191-20-011696:0
- 9,675 sharesCommon StockSEC:0001209191-20-010756:0
- 4,958 shares@ US$11.25Common StockSEC:0001209191-17-059945:0
- 15,000 sharesCommon StockSEC:0001209191-17-059399:0
- 3,309 shares@ US$10.06Common StockSEC:0001209191-16-150139:0
- 15,000 sharesCommon StockSEC:0001209191-16-148848:0
- 1,000 shares@ US$29.43Common StockSEC:0001209191-15-033114:0Canonical exit: 5 Jul 2015 (T+90)
- 2,000 shares@ US$33.00Common StockSEC:0001209191-15-033114:1Canonical exit: 6 Jul 2015 (T+90)
18 of 18 declarations
